A high burden of heart valve diseases is driving its expansion. India’s transcatheter aortic valve replacement (TAVR) market ...

GlobalData’s latest report reveals that India accounted for only around 3 per cent of the market in APAC in 2024, due to ...

Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this ...

Edwards Lifesciences Corp.’s posted fourth quarter results slightly ahead of expectations, but indicated that the first quarter of 2025 might not be as bright. The company expects growth for both its ...

Edwards Lifesciences stock popped Wednesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat.

Edwards Lifesciences (NYSE:EW) reported fourth-quarter sales of $1.39 billion, beating the consensus of $1.36 billion. This ...

Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to ...

The Heart and Vascular center at Portneuf Medical Center recently marked its 400th transaortic valve replacement procedure.